Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Faeth Therapeutics, Inc.

News headline image
Faeth Reports Positive Preliminary Phase 2 Topline Results from the PIK-201 Trial Evaluating PIKTOR in Combination with Paclitaxel in Patients with Advanced Endometrial Cancer
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth to Report PIK-201 Phase 2 Data and Host Virtual Event on November 9, 2026
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
Tickers FTH
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.